Latest rheumatoid arthritis Stories

Although some have suggested that patients receiving medication for immune-mediated diseases such as rheumatoid arthritis or psoriasis may be at increased risk of herpes zoster (HZ; shingles) shortly after receipt of the vaccine, an analysis that included nearly 20,000 vaccinated Medicare beneficiaries finds that the live zoster vaccine is not associated with an increased risk of HZ shortly after vaccination in patients currently treated with biologics, and that it is associated with a...

It's not just our DNA that makes us susceptible to disease and influences its impact and outcome. Scientists are beginning to realize more and more that important changes in genes that are unrelated to changes in the DNA sequence itself – a field of study known as epigenetics – are equally influential. A research team at the University of California, San Diego – led by Gary S. Firestein, professor in the Division of Rheumatology, Allergy and Immunology at UC San Diego School of...

In the realm of deadly and disabling diseases, conditions such as cancer and Alzheimer's seem to attract the most media attention. But there are others that take a similarly high toll, and rheumatoid arthritis is one of them, Mayo Clinic researchers say. It is a common cause of disability: 1 of every 5 rheumatoid arthritis patients is unable to work two years after diagnosis, and within five years, that rises to one-third. Life expectancy drops by up to five years, they write in the July...

(Ivanhoe Newswire) -- Pain, swelling, and loss of function in your joints are all symptoms of rheumatoid arthritis, but did you know that this condition is also the cause of unemployment? Approximately 1.3 million people in the United States suffer from Rheumatoid Arthritis. A new study is showing how these numbers directly relate to unemployment. In rheumatoid arthritis, the immune system assaults tissue, causing swollen and tender joints and sometimes involves other organs. 1 of every 5...

Regenerative medicine is now being used for treatment of Avascular Necrosis, according to A. J. Farshchian MD an Orthopedic Regenerative physician at the Center for Regenerative Medicine. (PRWEB) June 30, 2012 Regenerative medicine may help with Avascular Necrosis, according to A. J. Farshchian MD an Orthopedic Regenerative physician at the Center for Regenerative Medicine. Avascular necrosis can be quite devastating, and lead to total loss of the ankle joint with arthritis, deformity and...

Researchers at Northwestern University Feinberg School of Medicine have created the first animal model that spontaneously develops rheumatoid arthritis (RA) and is predisposed towards atherosclerosis, or hardening of the arteries. This model is considered of critical importance because patients with RA are at increased risk for heart attack and other premature cardiovascular events, but scientists don't know why. "Generally, people with RA die because of cardiovascular disease," said...

NORWALK, Conn., June 18, 2012 /PRNewswire/ -- UBM Medica US today announced that Musculoskeletal Network, an online resource for unique and efficient management of musculoskeletal disorders, now features a 5-article series on functional assessment in rheumatoid arthritis as an essential component of "treat to target" management strategies. The series, authored by Terence W. Starz, MD, and colleagues at the University of Pittsburgh School of Medicine, provides physicians with a...

DEERFIELD, Ill., June 18, 2012 /PRNewswire/ -- Horizon Pharma, Inc. (NASDAQ: HZNP) and Mallinckrodt LLC the Pharmaceuticals business of Covidien (NYSE: COV), announced today that they have entered into a U.S. co-promotion agreement for DUEXIS® (ibuprofen and famotidine), which is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers. "This collaboration with Mallinckrodt will...

ANAHEIM, Calif., June 14, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced key elements of the Company's initial commercialization plans for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of rheumatology-related indications already included on the FDA-approved package insert for Acthar. Acthar is indicated for multiple FDA-approved rheumatology-related conditions, including its use as adjunctive therapy in psoriatic...

NORWALK, Conn., June 13, 2012 /PRNewswire/ -- UBM Medica US today announced that Musculoskeletal Network, an online resource for unique and efficient techniques on the management of musculoskeletal disorders, now provides research highlights from the 2012 Annual Congress of the European League Against Rheumatism (EULAR), held in Berlin. EULAR's goal is to provide a forum for scientific, educational, and social exchange among professionals in rheumatology to achieve progress in the...